Lumateperone (Caplyta)

lumateperone · Intra-Cellular Therapies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lumateperone (Caplyta), covering 2024-08-16 to 2024-08-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder [Phase 1]

See pricing